Q2 2023 ImpediMed Ltd Activities Report Call Transcript
Thank you for standing by, and welcome to the ImpediMed Limited Quarterly Results Conference Call of Q2 FY23. (Operator Instructions)
I would now like to hand the conference over to Mr. Mike Bassett, Chief Commercial Officer. Please go ahead.
Thank you for joining us today. We are hosting this conference call to discuss our 4C for the financial quarter ending 31 December, 2022. I'm Mike Bassett, Chief Commercial Officer. Joining us on the call today is Rick Valencia, the new Managing Director and CEO of ImpediMed; Tim Cruickshank, our Chief Financial Officer; and Don Williams, Chair of the Board of ImpediMed.
We'll be referring to the 4C and speaking from the quarterly activity report we launched this morning, Australian time. This presentation is a summary of a more detailed 4C. After our remarks, we'll be taking questions.
Before I turn over to Don, I'd first like to bring to your attention the requisite disclaimer page that I recommend to you.
Now I'd
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |